Kamidono S, Arakawa S, Kataoka N, Fujii A, Ishigami J, Hirooka K, Hikosaka K, Saito H, Takahashi Y, Ito N
Hinyokika Kiyo. 1984 Apr;30(4):519-27.
Recurrence rate and symptoms after chemotherapy against acute uncomplicated cystitis (AUC) were studied. Upon completion of a 7-day treatment with two regimens, one of CEX alone (Group C) and the other of a combination of CEX with Lysozyme (Neuzym) (Group L), at a dose of 1 g CEX daily, efficacy of the drugs was assessed according to the criteria established by the UTI Study Group. The forty one cases in Group C and 38 cases in Group L showing an excellent response were evaluated for recurrence. The rates of recurrence were 12.2% in Group C and 21.1% in Group L during the first 7 days after treatment. In recurrent cases, bacteriuria was seen in 84.6% (11/13), pyuria in 53.8% (7/13) and miction pain in 30.8% (4/13). Thus, bacteriuria and pyuria should be the items of the criteria for AUC recurrence.
研究了急性单纯性膀胱炎（AUC）化疗后的复发率和症状。在用两种方案完成7天治疗后，一种方案是仅使用CEX（C组），另一种方案是CEX与溶菌酶（Neuzym）联合使用（L组），CEX每日剂量为1 g，根据UTI研究组制定的标准评估药物疗效。对C组的41例和L组的38例显示出极佳反应的病例进行复发评估。治疗后前7天，C组的复发率为12.2%，L组为21.1%。在复发病例中，84.6%（11/13）出现菌尿，53.8%（7/13）出现脓尿，30.8%（4/13）出现排尿疼痛。因此，菌尿和脓尿应作为AUC复发标准的项目。
